Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
about
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialCorrelation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.Facets of heat shock protein 70 show immunotherapeutic potential.Chaperokine-induced signal transduction pathways.Chronic inflammation in cancer development.Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.The complex function of hsp70 in metastatic cancer.HSP70-based anti-cancer immunotherapy.Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin.Mitochondrial HSP70 cognate-mediated differential expression of JNK1/2 in the pollution stressed grey mullets, Mugil cephalus.Introducing Professor Gabriele Multhoff, European Regional Editor.Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models.
P2860
Q26858884-E021EC6A-2001-48B4-8D4E-F8A1334AC852Q30315956-9FD297E3-8558-412B-832C-DAACADB7F33AQ35206769-41F72201-277D-40C3-8EE2-7C980C6EB670Q35611634-989E82D2-31F2-4FA9-9EDE-9EDA0A0379B2Q35928265-40A0DCDF-960E-429F-B2F5-3D30D70A3F34Q37170876-50BC319A-CE44-4935-A4B4-F9D8AB6A86B3Q37222064-54DD7A06-04F8-4715-A762-64F2D268EEEFQ38173257-12BB333D-EEBE-4DAD-856B-0E436DA1FB26Q39688737-14EAD805-7DAA-4819-BB79-3D41D0B84571Q39834388-6BF0FF2F-2A12-4C43-98F1-703C58F0A32BQ39958463-E8C6FD26-CBE4-455A-A57F-A50D7261C60FQ43792104-7D2DCE1F-762C-45B7-93BA-AE8025751756Q45305353-68C594E1-58F6-404C-8B18-2CFC5C78E509Q45889351-6D738EE4-5594-430E-8F6C-4A965081C892Q51664521-3DD5338E-DB35-4D0A-A655-C9EA85DBE98B
P2860
Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of tumor growth in ...... positive natural killer cells.
@en
Inhibition of tumor growth in ...... positive natural killer cells.
@nl
type
label
Inhibition of tumor growth in ...... positive natural killer cells.
@en
Inhibition of tumor growth in ...... positive natural killer cells.
@nl
prefLabel
Inhibition of tumor growth in ...... positive natural killer cells.
@en
Inhibition of tumor growth in ...... positive natural killer cells.
@nl
P2093
P2860
P1476
Inhibition of tumor growth in ...... positive natural killer cells
@en
P2093
Catharina Gross
Christian Moser
Christin Schmidbauer
Gerald Thonigs
Karin Pfister
Mathias Gehrmann
Ulrich Gürtler
P2860
P304
P356
10.1379/1466-1268(2002)007<0365:IOTGIM>2.0.CO;2
P577
2002-10-01T00:00:00Z